查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1902080

即时萤光定量PCR、数位萤光定量PCR和终点萤光定量PCR市场－全球产业规模、份额、趋势、机会和预测，按技术、产品、应用、地区和竞争格局划分，2021-2031年预测

Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球即时萤光定量PCR、数位PCR和终点PCR市场规模将从2025年的90.1亿美元成长到2031年的131.2亿美元，复合年增长率为6.46%。该市场涵盖了用于精确检测和定量遗传物质的先进核酸扩增技术。即时萤光定量PCR可实现即时监测，数位PCR可提供绝对定量，而终点PCR仍是定性分析的基础。

市场概览
预测期 2027-2031
市场规模：2025年 90.1亿美元
市场规模：2031年 131.2亿美元
复合年增长率：2026-2031年 6.46%
成长最快的细分市场 临床
最大的市场 北美洲

主要市场驱动因素

全球传染病和遗传性疾病的日益普及是推动市场发展的主要因素，也因此需要高通量、高灵敏度的诊断工具。随着癌症等慢性疾病负担的加重，人们越来越依赖即时和数位PCR技术进行生物标记定量和基因突变分析，以支持早期检测和个人化治疗策略。

主要市场挑战

发展中地区高昂的仪器成本和有限的诊断基础设施严重阻碍了全球即时萤光定量PCR、数位萤光定量PCR和终点萤光定量PCR市场的成长。先进的分子平台需要大量的设备前期投入和持续的耗材费用，这对于低收入地区的医疗系统而言是难以负担的。

主要市场趋势

用于检测多种病原体的多重PCR检测方法的广泛应用，显着改变了诊断流程，因为它能够从单一样本中同时识别多种标靶。这一趋势解决了重复检测效率低下的问题，尤其适用于胃肠道感染、脑膜炎和脓毒症等复杂的临床表现，在这些情况下，快速确定特定的致病因子对于患者管理至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球即时PCR、数位PCR与终点PCR市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术分类（定量、数位化、终端）
    • 依产品分类（耗材及试剂、仪器、软体及服务）
    • 按应用领域（临床、研究）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美即时PCR、数位PCR与终点PCR市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲即时PCR、数位PCR与终点PCR市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区即时PCR、数位PCR与终点PCR市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲实时PCR、数位PCR和终点PCR市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲即时PCR、数位PCR与终点PCR市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球即时萤光定量PCR、数位萤光定量PCR和终点萤光定量PCR市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Abbott Laboratories Inc
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific, Inc.
  • BIOMERIEUX SA
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Qiagen NV
  • Microsynth Ag

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 16090

The Global Real-time PCR, Digital PCR & End-point PCR Market will grow from USD 9.01 Billion in 2025 to USD 13.12 Billion by 2031 at a 6.46% CAGR. The Global Real-time PCR, Digital PCR & End-point PCR Market comprises advanced nucleic acid amplification technologies utilized for the precise detection and quantification of genetic materials. While real-time PCR enables immediate monitoring and digital PCR provides absolute quantification, end-point PCR remains fundamental for qualitative analysis.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.01 Billion
Market Size 2031USD 13.12 Billion
CAGR 2026-20316.46%
Fastest Growing SegmentClinical
Largest MarketNorth America

Key Market Drivers

The escalating global prevalence of infectious diseases and genetic disorders acts as a primary catalyst for the market, necessitating high-throughput and highly sensitive diagnostic tools. As the burden of chronic conditions like cancer intensifies, the reliance on real-time and digital PCR for biomarker quantification and genetic mutation analysis has surged to support early detection and personalized treatment strategies.

Key Market Challenges

High instrumentation costs and limited diagnostic infrastructure in developing regions significantly hinder the growth of the Global Real-time PCR, Digital PCR & End-point PCR Market. Advanced molecular platforms require substantial upfront capital for equipment and continuous funding for consumables which proves prohibitive for healthcare systems in low-income areas. These financial barriers prevent the widespread installation of PCR platforms in decentralized laboratories and confine the market largely to well-funded urban centers.

Key Market Trends

The proliferation of multiplex PCR assays for syndromic pathogen detection is significantly altering diagnostic workflows by enabling the simultaneous identification of numerous targets from a single specimen. This trend addresses the inefficiency of serial testing, particularly for complex clinical presentations such as gastrointestinal infections, meningitis, and sepsis, where identifying the specific causative agent rapidly is critical for patient management.

Key Market Players

  • Abbott Laboratories Inc
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific, Inc.
  • BIOMERIEUX SA
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Qiagen NV
  • Microsynth Ag

Report Scope:

In this report, the Global Real-time PCR, Digital PCR & End-point PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Real-time PCR, Digital PCR & End-point PCR Market, By Technology:

  • Quantitative
  • Digital
  • Endpoint

Real-time PCR, Digital PCR & End-point PCR Market, By Product:

  • Consumables & Reagents
  • Instruments
  • Software & Services

Real-time PCR, Digital PCR & End-point PCR Market, By Application:

  • Clinical
  • Research

Real-time PCR, Digital PCR & End-point PCR Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Real-time PCR, Digital PCR & End-point PCR Market.

Available Customizations:

Global Real-time PCR, Digital PCR & End-point PCR Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Quantitative, Digital, Endpoint)
    • 5.2.2. By Product (Consumables & Reagents, Instruments, Software & Services)
    • 5.2.3. By Application (Clinical, Research)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Application

7. Europe Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
    • 7.3.2. France Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Application

8. Asia Pacific Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. India Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application

9. Middle East & Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application

10. South America Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Real-time PCR, Digital PCR & End-point PCR Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. Thermo Fisher Scientific, Inc.
  • 15.4. BIOMERIEUX SA
  • 15.5. Fluidigm Corporation
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. GE Healthcare
  • 15.8. Agilent Technologies, Inc.
  • 15.9. Qiagen NV
  • 15.10. Microsynth Ag

16. Strategic Recommendations

17. About Us & Disclaimer